0000899243-19-017957.txt : 20190624 0000899243-19-017957.hdr.sgml : 20190624 20190624170522 ACCESSION NUMBER: 0000899243-19-017957 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190620 FILED AS OF DATE: 20190624 DATE AS OF CHANGE: 20190624 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DUNTON ALAN W CENTRAL INDEX KEY: 0001304773 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32188 FILM NUMBER: 19916084 MAIL ADDRESS: STREET 1: VICURON PHARMACEUTICALS INC STREET 2: 455 S GULPH ROAD SUITE 305 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORAGENICS INC CENTRAL INDEX KEY: 0001174940 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 593410522 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4902 EISENHOWER BLVD STREET 2: SUITE 125 CITY: TAMPA STATE: FL ZIP: 33634 BUSINESS PHONE: 8132867900 MAIL ADDRESS: STREET 1: 4902 EISENHOWER BLVD STREET 2: SUITE 125 CITY: TAMPA STATE: FL ZIP: 33634 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-20 0 0001174940 ORAGENICS INC OGEN 0001304773 DUNTON ALAN W 4902 EISENHOWER BOULEVARD TAMPA FL 33634 1 0 0 0 Non-Employee Director Option (Right to Buy) 0.48 2019-06-20 4 A 0 156540 A 2029-06-20 Common Stock 156540 156540 D Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a non-employee director. The option exercise price is the closing price on the date of the grant, June 20, 2019 (the "Grant Date"). The options vest quarterly in even amounts over the four quarters following the Grant Date. /s/ Mark A. Catchur, as Attorney-in-Fact for Alan W. Dunton 2019-06-24